These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18973922)

  • 1. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas.
    Vivekanandan P; Micchelli ST; Torbenson M
    Hum Pathol; 2009 Mar; 40(3):293-9. PubMed ID: 18973922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
    Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
    Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
    Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrolamellar carcinomas are positive for CD68.
    Ross HM; Daniel HD; Vivekanandan P; Kannangai R; Yeh MM; Wu TT; Makhlouf HR; Torbenson M
    Mod Pathol; 2011 Mar; 24(3):390-5. PubMed ID: 21113139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.
    Shafizadeh N; Ferrell LD; Kakar S
    Mod Pathol; 2008 Aug; 21(8):1011-8. PubMed ID: 18536657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
    Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
    Nault JC; Mallet M; Pilati C; Calderaro J; Bioulac-Sage P; Laurent C; Laurent A; Cherqui D; Balabaud C; Zucman-Rossi J
    Nat Commun; 2013; 4():2218. PubMed ID: 23887712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
    Tretiakova MS; Hart J; Shabani-Rad MT; Zhang J; Gao ZH
    Mod Pathol; 2009 Aug; 22(8):1113-20. PubMed ID: 19465902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
    Lee CT; Zhang L; Mounajjed T; Wu TT
    Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHIT mRNA and protein expression in hepatocellular carcinoma.
    Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M
    Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas.
    Vivekanandan P; Torbenson M
    Mod Pathol; 2008 Jun; 21(6):670-5. PubMed ID: 18264082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas.
    Vivekanandan P; Daniel H; Yeh MM; Torbenson M
    Mod Pathol; 2010 Jun; 23(6):790-8. PubMed ID: 20228784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.
    Washington K; Telen MJ; Gottfried MR
    Liver; 1997 Feb; 17(1):17-23. PubMed ID: 9062875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
    Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
    Graham RP; Jin L; Knutson DL; Kloft-Nelson SM; Greipp PT; Waldburger N; Roessler S; Longerich T; Roberts LR; Oliveira AM; Halling KC; Schirmacher P; Torbenson MS
    Mod Pathol; 2015 Jun; 28(6):822-9. PubMed ID: 25698061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma.
    Wilczek E; Szparecki G; Lukasik D; Koperski L; Winiarska M; Wilczynski GM; Wasiutynski A; Gornicka B
    PLoS One; 2012; 7(1):e30944. PubMed ID: 22292081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
    Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
    Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.